Giuliana Ferrari

The withdrawal of beti-cel therapy for β-Thalassemia from the European market: a multistakeholder perspective

Abstract This report aims to outline the complex and multifaceted framework within which the journey to European market access for a β-thalassemia gene therapy has unfolded, highlighting the clinical, ethical, economic, and regulatory challenges faced by all stakeholders involved...